Description

Indications

Letromina is indicated in treatment of breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy or as initial treatment of hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer

Presentation

Each carton contains 30 tablets of 2.5mg each.